We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




European Hospitals Instrumental in Spread of Drug-Resistant Bacteria

By HospiMedica International staff writers
Posted on 05 Aug 2019
Antibiotic-resistant strains of Klebsiella pneumoniae are spreading through hospitals in Europe, claims a new study.

Researchers at the University of Freiburg (Germany), the Centre for Genomic Pathogen Surveillance (Cambridge, United Kingdom), the University of Florence (Italy), and other institutions conducted a study to analyze genomic sequences and epidemiological data of over 1,700 K. More...
pneumoniae samples isolated from patients in 244 hospitals in 32 countries. The results revealed that acquisition of carbapenemase--an enzyme that renders the antibiotic carbapenem useless--is the main cause of resistance, occurring across diverse phylogenetic backgrounds.

They also found that 69.9% of the carbapenemase-positive isolates were concentrated in four clonal lineages and their derivatives. A subsequent analysis of the genetic and geographic distances between isolates with different β-lactam resistance determinants suggests that the propensity of K. pneumoniae to spread in hospital environments correlates with the degree of resistance. Over half of the hospitals that contributed carbapenemase-positive isolates probably experienced within-hospital transmission, and inter-hospital spread was far more frequent within, rather than between, countries. The study was published on July 29, 2019, in Nature Microbiology.

“The 'One Health' approach to antibiotic resistance focuses on the spread of pathogens through humans, animals, and the environment, including hospitals. But in the case of carbapenem-resistant K. pneumoniae, our findings imply hospitals are the key facilitator of transmission,” said lead author Sophia David, PhD, of the Centre for Genomic Pathogen Surveillance. “Over half of the samples carrying a carbapenemase gene were closely related to others collected from the same hospital, suggesting that the bacteria are spreading from person-to-person, primarily within hospitals.”

“We are optimistic that with good hospital hygiene, which includes early identification and isolation of patients carrying these bacteria, we can not only delay the spread of these pathogens, but also successfully control them,” said senior author Professor Hajo Grundmann, MD, head of the Institute for Infection Prevention and Hospital Hygiene at the University of Freiburg. “This research emphasises the importance of infection control and ongoing genomic surveillance of antibiotic-resistant bacteria to ensure we detect new resistant strains early, and act to combat the spread of antibiotic resistance.”

Horizontal gene transfer (HGT) is the primary mechanism for the spread of antibiotic resistance in bacteria. Genes responsible for antibiotic resistance in one species of bacteria can be transferred to another species of bacteria through various mechanisms of HGT such as transformation, transduction and conjugation, subsequently arming the antibiotic resistant genes' recipient against antibiotics. The rapid spread of antibiotic resistance genes in this manner is becoming medically challenging to deal with.

Related Links:
University of Freiburg
Centre for Genomic Pathogen Surveillance
University of Florence


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Ultrasonic Dissector
SONICBEAT
New
Endoscopy Display
E190
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: A research collaboration aims to further advance findings in human genomics research in cardiovascular diseases (Photo courtesy of 123RF)

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.